Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 75, Issue , 2017, Pages 94-105

  Mori, Marco Aurélio ^a   Meyer, Erika ^a   Soares, Ligia Mendes ^a   Milani, Humberto ^a   Guimarães, Francisco Silveira ^b   de Oliveira, Rúbia Maria Weffort ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bilateral common carotid arteries occlusion; Cannabidiol; Neuroplasticity; Neuroprotection; White matter

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABIDIOL; DOUBLECORTIN; MICROTUBULE ASSOCIATED PROTEIN 2; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; ANTIINFLAMMATORY AGENT; CALCIUM BINDING PROTEIN; DOUBLECORTIN PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANXIETY; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DRUG EFFECT; EMOTIONAL DISORDER; GLIA; HIPPOCAMPUS; HOPELESSNESS; MALE; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; SHORT COURSE THERAPY; WHITE MATTER INJURY; ANIMAL; C57BL MOUSE; COMPLICATION; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; EXPLORATORY BEHAVIOR; MAZE TEST; METABOLISM; PSYCHOLOGY; RECOGNITION; SWIMMING; TIME FACTOR;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN ISCHEMIA; CALCIUM-BINDING PROTEINS; CANNABIDIOL; DISEASE MODELS, ANIMAL; ENCEPHALITIS; EXPLORATORY BEHAVIOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL PLASTICITY; NEUROPEPTIDES; RECOGNITION (PSYCHOLOGY); RECOVERY OF FUNCTION; SWIMMING; TIME FACTORS;

EID: 85010450370     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2016.11.005     Document Type: Article

References (86)

1. Alvarez, F.J., Lafuente, H., Rey-Santano, M.C., Mielgo, V.E., Gastiasoro, E., Rueda, M., et al. Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets. Pediatr. Res. 64 (2008), 653–658.
2. Bacarin, C.C., Godinho, J., de Oliveira, R.M., Matsushita, M., Gohara, A.K., Cardozo-Filho, L., et al. Postischemic fish oil treatment restores long-term retrograde memory and dendritic density: an analysis of the time window of efficacy. Behav. Brain Res. 311 (2016), 425–439.
3. Balkaya, M., Krober, J., Gertz, K., Peruzzaro, S., Endres, M., Characterization of long-term functional outcome in a murine model of mild brain ischemia. J. Neurosci. Methods 213 (2013), 179–187.
4. Beck, T., Lindholm, D., Castren, E., Wree, A., Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 14 (1994), 689–692.
5. Biffi, A., Bailey, D., Anderson, C.D., Ayres, A.M., Gurol, E.M., Greenberg, S.M., et al. Risk factors associated with early vs delayed dementia after intracerebral hemorrhage. JAMA Neurology 73 (2016), 969–976.
6. Blasi, F., Wei, Y., Balkaya, M., Tikka, S., Mandeville, J.B., Waeber, C., et al. Recognition memory impairments after subcortical white matter stroke in mice. Stroke; A Journal of Cerebral Circulation 45 (2014), 1468–1473.
7. Blondeau, N., Nguemeni, C., Debruyne, D.N., Piens, M., Wu, X., Pan, H., et al. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34 (2009), 2548–2559.
8. Bolandzadeh, N., Davis, J.C., Tam, R., Handy, T.C., Liu-Ambrose, T., The association between cognitive function and white matter lesion location in older adults: a systematic review. BMC Neurol., 12, 2012, 126.
9. Braida, D., Pegorini, S., Arcidiacono, M.V., Consalez, G.G., Croci, L., Sala, M., Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils. Neurosci. Lett. 346 (2003), 61–64.
10. Briones, T.L., Suh, E., Jozsa, L., Woods, J., Behaviorally induced synaptogenesis and dendritic growth in the hippocampal region following transient global cerebral ischemia are accompanied by improvement in spatial learning. Exp. Neurol. 198 (2006), 530–538.
11. Brown, J.P., Couillard-Despres, S., Cooper-Kuhn, C.M., Winkler, J., Aigner, L., Kuhn, H.G., Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 467 (2003), 1–10.
12. Campos, A.C., Guimaraes, F.S., Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 199 (2008), 223–230.
13. Campos, A.C., Ortega, Z., Palazuelos, J., Fogaça, M.V., Aguiar, D.C., Díaz-Alonso, J., Ortega-Gutiérrez, S., Vázquez-Villa, H., Moreira, F.A., Guzmán, M., Galve-Roperh, I., Guimarães, F.S., The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. Int. J. Neuropsychopharmacol 16 (2013), 1407–1419.
14. Campos, A.C., Brant, F., Miranda, A.S., Machado, F.S., Teixeira, A.L., Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria. Neuroscience 289 (2015), 166–180.
15. Campos, A.C., Ferreira, F.R., Guimaraes, F.S., Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. J. Psychiatr. Res. 46 (2012), 1501–1510.
16. Campos, A.C., Fogaca, M.V., Sonego, A.B., Guimaraes, F.S., Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol. Res., 2016.
17. Campos, A.C., Moreira, F.A., Gomes, F.V., Del Bel, E.A., Guimaraes, F.S., Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 367 (2012), 3364–3378.
18. Carola, V., D'Olimpio, F., Brunamonti, E., Mangia, F., Renzi, P., Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav. Brain Res. 134 (2002), 49–57.
19. Castillo, A., Tolon, M.R., Fernandez-Ruiz, J., Romero, J., Martinez-Orgado, J., The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol. Dis. 37 (2010), 434–440.
20. Castren, E., Voikar, V., Rantamaki, T., Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 7 (2007), 18–21.
21. Cheng, D., Spiro, A.S., Jenner, A.M., Garner, B., Karl, T., Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice. Journal of Alzheimer's Disease: JAD 42 (2014), 1383–1396.
22. Cibelli, M., Fidalgo, A.R., Terrando, N., Ma, D., Monaco, C., Feldmann, M., et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann. Neurol. 68 (2010), 360–368.
23. da Silva, V.K., de Freitas, B.S., da Silva, D.A., Nery, L.R., Falavigna, L., Ferreira, R.D., et al. Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection. Mol. Neurobiol. 49 (2014), 222–233.
24. Dellu, F., Contarino, A., Simon, H., Koob, G.F., Gold, L.H., Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol. Learn. Mem. 73 (2000), 31–48.
25. Di Stefano, G., Casoli, T., Fattoretti, P., Gracciotti, N., Solazzi, M., Bertoni-Freddari, C., Distribution of MAP2 in hippocampus and cerebellum of young and old rats by quantitative immunohistochemistry. J. Histochem. Cytochem. 49 (2001), 1065–1066.
26. Dirnagl, U., Endres, M., Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes. Stroke; A Journal of Cerebral Circulation 45 (2014), 1510–1518.
27. Fernandez-Ruiz, J., Sagredo, O., Pazos, M.R., Garcia, C., Pertwee, R., Mechoulam, R., et al. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?. Br. J. Clin. Pharmacol. 75 (2013), 323–333.
28. Flynn, R.W., MacWalter, R.S., Doney, A.S., The cost of cerebral ischaemia. Neuropharmacology 55 (2008), 250–256.
29. Franklin, K.B.J., Paxinos, G., The Mouse Brain in Stereotaxic Coordinates. 2th Edn., 1997, Academic Press, San Diego.
30. Garcia-Arencibia, M., Gonzalez, S., de Lago, E., Ramos, J.A., Mechoulam, R., Fernandez-Ruiz, J., Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res. 1134 (2007), 162–170.
31. Garcia-Chavez, D., Gonzalez-Burgos, I., Letechipia-Vallejo, G., Lopez-Loeza, E., Morali, G., Cervantes, M., Long-term evaluation of cytoarchitectonic characteristics of prefrontal cortex pyramidal neurons, following global cerebral ischemia and neuroprotective melatonin treatment, in rats. Neurosci. Lett. 448 (2008), 148–152.
32. Gehrmann, J., Bonnekoh, P., Miyazawa, T., Hossmann, K.A., Kreutzberg, G.W., Immunocytochemical study of an early microglial activation in ischemia. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 12 (1992), 257–269.
33. Geri, G., Mongardon, N., Daviaud, F., Empana, J.P., Dumas, F., Cariou, A., Neurological consequences of cardiac arrest: where do we stand?. Annales francaises d'anesthesie et de reanimation 33 (2014), 98–101.
34. Ginsberg, M.D., Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke; A Journal of Cerebral Circulation 40 (2009), S111–S114.
35. Gomes, F.V., Llorente, R., Del Bel, E.A., Viveros, M.P., Lopez-Gallardo, M., Guimaraes, F.S., Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. Schizophr. Res. 164 (2015), 155–163.
36. Graeber, M.B., Li, W., Rodriguez, M.L., Role of microglia in CNS inflammation. FEBS Lett. 585 (2011), 3798–3805.
37. Guimaraes, F.S., Chiaretti, T.M., Graeff, F.G., Zuardi, A.W., Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100 (1990), 558–559.
38. Hall, E.D., Traystman, R.J., Role of animal studies in the design of clinical trials. Frontiers of Neurology and Neuroscience 25 (2009), 10–33.
39. Hayakawa, K., Irie, K., Sano, K., Watanabe, T., Higuchi, S., Enoki, M., et al. Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism. Biol. Pharm. Bull. 32 (2009), 1538–1544.
40. Hayakawa, K., Mishima, K., Irie, K., Hazekawa, M., Mishima, S., Fujioka, M., et al. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism. Neuropharmacology 55 (2008), 1280–1286.
41. Johansen, F.F., Jorgensen, M.B., Ekstrom von Lubitz, D.K., Diemer, N.H., Selective dendrite damage in hippocampal CA1 stratum radiatum with unchanged axon ultrastructure and glutamate uptake after transient cerebral ischaemia in the rat. Brain Res.(291), 1984, 373–377.
42. Jones, L., Fischer, I., Levitt, P., Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb. Cortex 6 (1996), 431–445.
43. Kim, A.S., Johnston, S.C., Global variation in the relative burden of stroke and ischemic heart disease. Circulation 124 (2011), 314–323.
44. Kim, Y.R., Kim, H.N., Hong, K.W., Shin, H.K., Choi, B.T., Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke. Psychopharmacology 233 (2016), 1055–1066.
45. Kim, D.H., Li, H., Yoo, K.Y., Lee, B.H., Hwang, I.K., Won, M.H., Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. 204 (2007), 748–758.
46. Kim, J.B., Sig Choi, J., Yu, Y.M., Nam, K., Piao, C.S., Kim, S.W., et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. Off. J. Soc. Neurosci. 26 (2006), 6413–6421.
47. Kiryk, A., Pluta, R., Figiel, I., Mikosz, M., Ulamek, M., Niewiadomska, G., et al. Transient brain ischemia due to cardiac arrest causes irreversible long-lasting cognitive injury. Behav. Brain Res. 219 (2011), 1–7.
48. Kouhsar, S.S., Karami, M., Tafreshi, A.P., Roghani, M., Nadoushan, M.R., Microinjection of l-arginine into corpus callosum cause reduction in myelin concentration and neuroinflammation. Brain Res. 1392 (2011), 93–100.
49. Kronenberg, G., Gertz, K., Heinz, A., Endres, M., Of mice and men: modelling post-stroke depression experimentally. Br. J. Pharmacol. 171 (2014), 4673–4689.
50. Lafuente, H., Alvarez, F.J., Pazos, M.R., Alvarez, A., Rey-Santano, M.C., Mielgo, V., et al. Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs. Pediatr. Res. 70 (2011), 272–277.
51. Lee, C.H., Park, J.H., Yoo, K.Y., Choi, J.H., Hwang, I.K., Ryu, P.D., et al. Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress. Exp. Neurol. 229 (2011), 450–459.
52. Lei, S., Zhang, P., Li, W., Gao, M., He, X., Zheng, J., et al. Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats. ASN Neuro., 6, 2014.
53. Leo, A., Russo, E., Elia, M., Cannabidiol and epilepsy: rationale and therapeutic potential. Pharmacol. Res. 107 (2016), 85–92.
54. Li, Y., Jiang, N., Powers, C., Chopp, M., Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke; A Journal of Cerebral Circulation 29 (1998), 1972–1980 (discussion 80-1).
55. Martin-Moreno, A.M., Reigada, D., Ramirez, B.G., Mechoulam, R., Innamorato, N., Cuadrado, A., et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol. Pharmacol. 79 (2011), 964–973.
56. Mechoulam, R., Gaoni, Y., A total synthesis of DL-delta-1-tetrahydrocannabinol, the active constituent of hashish. J. Am. Chem. Soc. 87 (1965), 3273–3275.
57. Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., et al. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke; A Journal of Cerebral Circulation 36 (2005), 1077–1082.
58. Moreira, F.A., Aguiar, D.C., Guimaraes, F.S., Anxiolytic-like effect of cannabidiol in the rat vogel conflict test. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 30 (2006), 1466–1471.
59. Moriyama, Y., Takagi, N., Tanonaka, K., Intravenous injection of neural progenitor cells improved depression-like behavior after cerebral ischemia. Transl. Psychiatry, 1, 2011, e29.
60. Moulaert, V.R., Wachelder, E.M., Verbunt, J.A., Wade, D.T., van Heugten, C.M., Determinants of quality of life in survivors of cardiac arrest. J. Rehabil. Med. 42 (2010), 553–558.
61. Nakashima, M.N., Ajiki, K., Nakashima, K., Takahashi, M., Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice. J. Pharmacol. Sci. 91 (2003), 47–52.
62. Neigh, G.N., Karelina, K., Glasper, E.R., Bowers, S.L., Zhang, N., Popovich, P.G., et al. Anxiety after cardiac arrest/cardiopulmonary resuscitation: Exacerbated by stress and prevented by minocycline. Stroke; A Journal of Cerebral Circulation 40 (2009), 3601–3607.
63. Pang, C., Cao, L., Wu, F., Wang, L., Wang, G., Yu, Y., et al. The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis. Neuropharmacology 97 (2015), 447–456.
64. Pazos, M.R., Cinquina, V., Gomez, A., Layunta, R., Santos, M., Fernandez-Ruiz, J., et al. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology 63 (2012), 776–783.
65. Pazos, M.R., Mohammed, N., Lafuente, H., Santos, M., Martinez-Pinilla, E., Moreno, E., et al. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology 71 (2013), 282–291.
66. Pertwee, R.G., Thomas, A., Stevenson, L.A., Maor, Y., Mechoulam, R., Evidence that (−)-7-hydroxy-4′-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens. Neuropharmacology 48 (2005), 1139–1146.
67. Porsolt, R.D., Bertin, A., Jalfre, M., Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 51 (1978), 291–294.
68. Resstel, L.B., Joca, S.R., Moreira, F.A., Correa, F.M., Guimaraes, F.S., Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav. Brain Res. 172 (2006), 294–298.
69. Rutten, K., Lieben, C., Smits, L., Blokland, A., The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology 192 (2007), 275–282.
70. Schabitz, W.R., Schwab, S., Spranger, M., Hacke, W., Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 17 (1997), 500–506.
71. Schiavon, A.P., Soares, L.M., Bonato, J.M., Milani, H., Guimaraes, F.S., Weffort de Oliveira, R.M., Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox. Res. 26 (2014), 307–316.
72. Seif el Nasr, M., Nuglisch, J., Krieglstein, J., Prevention of ischemia-induced cerebral hypothermia by controlling the environmental temperature. J. Pharmacol. Toxicol. Methods 27 (1992), 23–26.
73. Shibata, M., Yamasaki, N., Miyakawa, T., Kalaria, R.N., Fujita, Y., Ohtani, R., et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke; A Journal of Cerebral Circulation 38 (2007), 2826–2832.
74. Soares, L.M., De Vry, J., Steinbusch, H.W., Milani, H., Prickaerts, J., Weffort de Oliveira, R.M., Rolipram improves cognition, reduces anxiety- and despair-like behaviors and impacts hippocampal neuroplasticity after transient global cerebral ischemia. Neuroscience 326 (2016), 69–83.
75. Soares, L.M., Schiavon, A.P., Milani, H., de Oliveira, R.M., Cognitive impairment and persistent anxiety-related responses following bilateral common carotid artery occlusion in mice. Behav. Brain Res. 249 (2013), 28–37.
76. Stoll, M., Capper, D., Dietz, K., Warth, A., Schleich, A., Schlaszus, H., et al. Differential microglial regulation in the human spinal cord under normal and pathological conditions. Neuropathol. Appl. Neurobiol. 32 (2006), 650–661.
77. Taguchi, N., Nakayama, S., Tanaka, M., Single administration of soluble epoxide hydrolase inhibitor suppresses neuroinflammation and improves neuronal damage after cardiac arrest in mice. Neurosci. Res., 2016.
78. Ueno, Y., Zhang, N., Miyamoto, N., Tanaka, R., Hattori, N., Urabe, T., Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model. Neuroscience 162 (2009), 317–327.
79. Wakita, H., Tomimoto, H., Akiguchi, I., Matsuo, A., Lin, J.X., Ihara, M., McGeer, P.L., Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res. 924 (2002), 63–70.
80. Wu, D., Pardridge, W.M., Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 254–259.
81. Yan, B.C., Park, J.H., Ahn, J.H., Lee, J.C., Won, M.H., Kang, I.J., Postsynaptic density protein (PSD)-95 expression is markedly decreased in the hippocampal CA1 region after experimental ischemia-reperfusion injury. J. Neurol. Sci. 330 (2013), 111–116.
82. Yasuda, Y., Shimoda, T., Uno, K., Tateishi, N., Furuya, S., Tsuchihashi, Y., et al. Temporal and sequential changes of glial cells and cytokine expression during neuronal degeneration after transient global ischemia in rats. J. Neuroinflammation, 8, 2011, 70.
83. Yoshioka, H., Niizuma, K., Katsu, M., Sakata, H., Okami, N., Chan, P.H., Consistent injury to medium spiny neurons and white matter in the mouse striatum after prolonged transient global cerebral ischemia. J. Neurotrauma 28 (2011), 649–660.
84. Zepeda, A., Sengpiel, F., Guagnelli, M.A., Vaca, L., Arias, C., Functional reorganization of visual cortex maps after ischemic lesions is accompanied by changes in expression of cytoskeletal proteins and NMDA and GABA(A) receptor subunits. J. Neurosci. Off. J. Soc. Neurosci. 24 (2004), 1812–1821.
85. Zhang, C., Wu, H., Zhu, X., Wang, Y., Guo, J., Role of transcription factors in neurogenesis after cerebral ischemia. Rev. Neurosci. 22 (2011), 457–465.
86. Zhang, R., Zhang, Z., Zhang, C., Zhang, L., Robin, A., Wang, Y., et al. Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat. J. Neurosci. Off. J. Soc. Neurosci. 24 (2004), 5810–5815.